<html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:svg="http://www.w3.org/2000/svg" lang="en" xml:lang="en">
<head>
<title>Chapter Review in Chapter 22 Biosynthesis of Amino Acids, Nucleotides, and Related Molecules</title>
<meta charset="utf-8"/>
<meta content="final" name="process"/>
<meta content="part" name="book_type"/>
<meta content="3.3" name="schema"/>
<link href="../styles/nel_9781319228002.css" rel="stylesheet" type="text/css"/>
<meta content="urn:uuid:e0000000-0000-0000-0000-000006631217" name="Adept.expected.resource"/>
</head>
<body class="bodymatter" epub:type="bodymatter">
<section class="end-of-section" id="dav_9781319322342_qsQtGDfzV1">
<header id="dav_9781319322342_NeLt4Hp4c9"><h3 class="title v1" epub:type="title" id="dav_9781319322342_elHC067665">Chapter Review</h3></header>
<section class="learning-resources v3" epub:type="learning-resources" id="dav_9781319322342_sezVH6OPRb">
<header id="dav_9781319322342_11koMhSg9L"><h4 class="title v3" epub:type="title" id="dav_9781319322342_w8ZP5FlO2a">KEY TERMS</h4></header>
<p class="noindent" id="dav_9781319322342_6J3p98eqly"><i class="semantic-i" id="dav_9781319322342_taNBHMATpi">Terms in bold are defined in the glossary.</i></p>
<ul class="ul-no-mark" id="dav_9781319322342_NqxV9TPjpC">
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_lAmgESyvOe"><strong class="important" id="dav_9781319322342_C2vbRWVXIS"><a class="crossref" href="nel_9781319228002_ch22_02.xhtml#dav_9781319322342_jFWMvptoHr" id="dav_9781319322342_E2YkXfMHQP">nitrogen fixation</a></strong></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_TvAjMtn6wp"><a class="crossref" href="nel_9781319228002_ch22_02.xhtml#dav_9781319322342_gQL8wGaDvr" id="dav_9781319322342_OFELfkvVEM">nitrification</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_yrb6xSbCTZ"><a class="crossref" href="nel_9781319228002_ch22_02.xhtml#dav_9781319322342_EC2RPDaAX4" id="dav_9781319322342_FqezUH1LYX">denitrification</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_9p1SDzYMEc"><strong class="important" id="dav_9781319322342_kqDER1U4lt"><a class="crossref" href="nel_9781319228002_ch22_02.xhtml#dav_9781319322342_ZAA2lOeLGb" id="dav_9781319322342_SlM7jY0Eq8">anammox</a></strong></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_TjxgdJ0S3y"><strong class="important" id="dav_9781319322342_uYxhePmait"><a class="crossref" href="nel_9781319228002_ch22_02.xhtml#dav_9781319322342_sWlDpH3FM1" id="dav_9781319322342_nx04Fndt8e">symbionts</a></strong></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_9TW6SAtW0H"><strong class="important" id="dav_9781319322342_BBAnztn4t4"><a class="crossref" href="nel_9781319228002_ch22_02.xhtml#dav_9781319322342_1eTJUhb2jf" id="dav_9781319322342_cpWxlVT2bp">nitrogenase complex</a></strong></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_57joYbC1Zd"><a class="crossref" href="nel_9781319228002_ch22_02.xhtml#dav_9781319322342_h1ELkSxkVK" id="dav_9781319322342_VZJarlwc5L">FeMo cofactor</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_zJAECjwYkw"><a class="crossref" href="nel_9781319228002_ch22_02.xhtml#dav_9781319322342_pS33xJDNeU" id="dav_9781319322342_h1lbb4RMYY">ferredoxin</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_qVEPINgmFz"><a class="crossref" href="nel_9781319228002_ch22_02.xhtml#dav_9781319322342_TopAofm6CE" id="dav_9781319322342_ZgwZpW7fle">leghemoglobin</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_edh2wud8yX"><a class="crossref" href="nel_9781319228002_ch22_02.xhtml#dav_9781319322342_jKKfHrNLe0" id="dav_9781319322342_3kNHVeEkvp">glutamate</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_DKTl7A4WlP"><a class="crossref" href="nel_9781319228002_ch22_02.xhtml#dav_9781319322342_WDrsbbpoZU" id="dav_9781319322342_xc0kjNecTO">glutamine</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_9Hni6f3pEL"><a class="crossref" href="nel_9781319228002_ch22_02.xhtml#dav_9781319322342_Bui2tq5knP" id="dav_9781319322342_Smjwb3Uvvv">glutamine synthetase</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_0Rnj0rT3XH"><a class="crossref" href="nel_9781319228002_ch22_02.xhtml#dav_9781319322342_Jj8sgKcK7i" id="dav_9781319322342_z21hPwWbPs">glutamate synthase</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_7eR9wKs4IQ"><a class="crossref" href="nel_9781319228002_ch22_02.xhtml#dav_9781319322342_qCDiGBxjxK" id="dav_9781319322342_tigYoRUESe">glutamine amidotransferases</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_Wz1wMqVCgf"><a class="crossref" href="nel_9781319228002_ch22_03.xhtml#dav_9781319322342_5c03f7yIkn" id="dav_9781319322342_GjgCXlANmP">5-phosphoribosyl-1-pyrophosphate (PRPP)</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_yoUHOQlDsy"><strong class="important" id="dav_9781319322342_bSSa68MUXG"><a class="crossref" href="nel_9781319228002_ch22_04.xhtml#dav_9781319322342_rqwM4QmDpD" id="dav_9781319322342_ppn3JKBeAC">porphyrin</a></strong></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_RHSCf7eUiv"><strong class="important" id="dav_9781319322342_ESJiDo0G6p"><a class="crossref" href="nel_9781319228002_ch22_04.xhtml#dav_9781319322342_jDgUkNliEe" id="dav_9781319322342_8fpfZJBqyE">porphyria</a></strong></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_OHCqg4APuy"><a class="crossref" href="nel_9781319228002_ch22_04.xhtml#dav_9781319322342_EgUq465ZLw" id="dav_9781319322342_tsc2B7fF0U">bilirubin</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_kvHK3cRcd6"><a class="crossref" href="nel_9781319228002_ch22_04.xhtml#dav_9781319322342_U2Ruajnyzk" id="dav_9781319322342_6oWegxPTB8">phosphocreatine</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_oKM7wgCXes"><a class="crossref" href="nel_9781319228002_ch22_04.xhtml#dav_9781319322342_G6P8SpIwSU" id="dav_9781319322342_3v0dUTzsWE">creatine</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_NXcX2F6ylD"><a class="crossref" href="nel_9781319228002_ch22_04.xhtml#dav_9781319322342_GmrXCwOVKG" id="dav_9781319322342_SVDr69j9On">glutathione (GSH)</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_9uylDaXiUX"><strong class="important" id="dav_9781319322342_xWxwV07oFr"><a class="crossref" href="nel_9781319228002_ch22_04.xhtml#dav_9781319322342_mVZRr9TlbO" id="dav_9781319322342_KEca9Hr9Hk">auxin</a></strong></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_a0e95SZrUs"><a class="crossref" href="nel_9781319228002_ch22_04.xhtml#dav_9781319322342_VHNuIyOCyr" id="dav_9781319322342_hndYGvYH5F">dopamine</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_Cv4Wc4SYLv"><a class="crossref" href="nel_9781319228002_ch22_04.xhtml#dav_9781319322342_9tuxykd2B8" id="dav_9781319322342_ioaam7iY1C">norepinephrine</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_Bf3NKW1N4e"><a class="crossref" href="nel_9781319228002_ch22_04.xhtml#dav_9781319322342_3bPVq6kVDb" id="dav_9781319322342_jkDChfwRwB">epinephrine</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_ABgYJtMDb8"><a class="crossref" href="nel_9781319228002_ch22_04.xhtml#dav_9781319322342_ZoqecmDf5K" id="dav_9781319322342_MAf2DW1QMP"><i class="semantic-i" id="dav_9781319322342_CEu6Myk8sH">γ</i>-aminobutyrate (GABA)</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_b01ZCAzEEQ"><a class="crossref" href="nel_9781319228002_ch22_04.xhtml#dav_9781319322342_paO6s3l4HC" id="dav_9781319322342_JXcv1iEayV">serotonin</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_NfFgywHJLL"><a class="crossref" href="nel_9781319228002_ch22_04.xhtml#dav_9781319322342_RMTG26P8Hl" id="dav_9781319322342_IeL3xl8Q0D">histamine</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_WWMvGf1yF4"><a class="crossref" href="nel_9781319228002_ch22_04.xhtml#dav_9781319322342_VKnPGODhXI" id="dav_9781319322342_tJa7uvVk1F">spermine</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_tqssI5MIyg"><a class="crossref" href="nel_9781319228002_ch22_04.xhtml#dav_9781319322342_y00uCnHSN5" id="dav_9781319322342_JoKuyq2JaT">spermidine</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_4IEhRyEe9C"><a class="crossref" href="nel_9781319228002_ch22_04.xhtml#dav_9781319322342_guxoJ0gpba" id="dav_9781319322342_0ooVK64Tna">ornithine decarboxylase</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_2TAZUFzf8D"><strong class="important" id="dav_9781319322342_2LJIakmKbJ"><a class="crossref" href="nel_9781319228002_ch22_05.xhtml#dav_9781319322342_Gzywb6ziRd" id="dav_9781319322342_189vPVzpk2">de novo pathway</a></strong></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_WJWAqLIfXM"><strong class="important" id="dav_9781319322342_zYF69PfgkZ"><a class="crossref" href="nel_9781319228002_ch22_05.xhtml#dav_9781319322342_Ab66QEfXvS" id="dav_9781319322342_jTieJukEJz">salvage pathway</a></strong></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_FKuFhToJRZ"><a class="crossref" href="nel_9781319228002_ch22_05.xhtml#dav_9781319322342_VOVEISPo70" id="dav_9781319322342_cHnYJC2DWA">inosinate (IMP)</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_fSEUiD0iqv"><a class="crossref" href="nel_9781319228002_ch22_05.xhtml#dav_9781319322342_2xDQjA6iIp" id="dav_9781319322342_1D5XGp4ApQ">carbamoyl phosphate synthetase II</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_06ZVnc5T4G"><a class="crossref" href="nel_9781319228002_ch22_05.xhtml#dav_9781319322342_tPqs7lwwdk" id="dav_9781319322342_2giJTnFaWd">aspartate transcarbamoylase</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_sGSWx8bZSU"><strong class="important" id="dav_9781319322342_82NF9Jtj7G"><a class="crossref" href="nel_9781319228002_ch22_05.xhtml#dav_9781319322342_wOJ9b1Uymy" id="dav_9781319322342_7HOj2kVWET">nucleoside monophosphate kinase</a></strong></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_ktdLYUNCXO"><strong class="important" id="dav_9781319322342_BFBK8A3c9J"><a class="crossref" href="nel_9781319228002_ch22_05.xhtml#dav_9781319322342_zm72v0c38z" id="dav_9781319322342_tVCQGlr8tN">nucleoside diphosphate kinase</a></strong></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_NOVy9eoChP"><a class="crossref" href="nel_9781319228002_ch22_05.xhtml#dav_9781319322342_RtioMmD8GG" id="dav_9781319322342_wqWTE1FEL2">ribonucleotide reductase</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_Rinv0ZrWFc"><strong class="important" id="dav_9781319322342_2fJKAmkDau"><a class="crossref" href="nel_9781319228002_ch22_05.xhtml#dav_9781319322342_1PwlRkpxgu" id="dav_9781319322342_L0vTNCyjLe">thioredoxin</a></strong></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_fnW1v5107K"><a class="crossref" href="nel_9781319228002_ch22_05.xhtml#dav_9781319322342_vpbTkkGSZ9" id="dav_9781319322342_m1xEnQhMSS">thymidylate synthase</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_hC3RQrm3hX"><a class="crossref" href="nel_9781319228002_ch22_05.xhtml#dav_9781319322342_5c9H2NUuU9" id="dav_9781319322342_0IL1xeSiO5">dihydrofolate reductase</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_VU50Hj3r6x"><a class="crossref" href="nel_9781319228002_ch22_05.xhtml#dav_9781319322342_4hxbcYJsSC" id="dav_9781319322342_Vm1txdTFKE">adenosine deaminase (ADA) deficiency</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_ixiKjeQ6HI"><a class="crossref" href="nel_9781319228002_ch22_05.xhtml#dav_9781319322342_FQXw9bnZII" id="dav_9781319322342_xzymxW6DJ6">Lesch-Nyhan syndrome</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_XvxkCegR3T"><a class="crossref" href="nel_9781319228002_ch22_05.xhtml#dav_9781319322342_K5NW677kMf" id="dav_9781319322342_VN7JmXcVg2">allopurinol</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_2wkXzWnewa"><a class="crossref" href="nel_9781319228002_ch22_05.xhtml#dav_9781319322342_jh96gndq1e" id="dav_9781319322342_HPvegnAyIE">fluorouracil</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_yzCnnj1oA9"><a class="crossref" href="nel_9781319228002_ch22_05.xhtml#dav_9781319322342_Ir1GIKW9yS" id="dav_9781319322342_kLXhD1L9kf">methotrexate</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_qCVsMFRt2y"><a class="crossref" href="nel_9781319228002_ch22_05.xhtml#dav_9781319322342_dVYomj5bE8" id="dav_9781319322342_XdMb43uwaP">aminopterin</a></li>
<li class="learning-resource" epub:type="learning-resource" id="dav_9781319322342_uydXqvsNaP"><a class="crossref" href="nel_9781319228002_ch22_05.xhtml#dav_9781319322342_vWDqPR2VT0" id="dav_9781319322342_c0N2NveJbi">trimethoprim</a></li>
</ul>
</section>
<section class="practice" epub:type="practice" id="dav_9781319322342_27WBLGylN9">
<header id="dav_9781319322342_6Oz4ksYyCQ"><h4 class="title cap v4" epub:type="title" id="dav_9781319322342_MDTMVx0jX8">Problems</h4></header>
<ul class="ul-no-mark" id="dav_9781319322342_pkUsnWccLk">
<li id="dav_9781319322342_wGAAiX1ihV"><p class="question noindent" epub:type="question" id="dav_9781319322342_7gHU5YOJfO"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_fHFEC4IZuh" id="dav_9781319322342_fOYfkmuHhX">1</a>. <strong class="important" id="dav_9781319322342_PmmRUGDS4x">ATP Consumption by Root Nodules in Legumes</strong> Bacteria residing in the root nodules of the pea plant consume more than 20% of the ATP produced by the plant. Suggest why these bacteria consume so much ATP.</p></li>
<li id="dav_9781319322342_6hBBBJdAWZ"><p class="question noindent" epub:type="question" id="dav_9781319322342_I3wxEhiVPw"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_TkqJKDWPfu" id="dav_9781319322342_3UBUGktpzZ">2</a>. <strong class="important" id="dav_9781319322342_UwfhhxNWda">Nitrate Fertilizers and Oceanic Dead Zones</strong> Farmers apply industrially fixed nitrogen, in the form of ammonia or nitrate, to agricultural fields worldwide to increase crop yields. Agricultural runoff feeds into rivers and creates large hypoxic dead zones at the point where rivers meet oceans. How does an increase in soluble fixed nitrogen create dead zones?</p></li>
<li id="dav_9781319322342_JtkRPmqoNc"><p class="question noindent" epub:type="question" id="dav_9781319322342_XiC74MghvR"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_T9g8fMjJV6" id="dav_9781319322342_PnAwEMoOPG">3</a>. <strong class="important" id="dav_9781319322342_4Vhfna9jET">PLP Reaction Mechanisms</strong> Pyridoxal phosphate (PLP) can help catalyze transformations one or two carbons removed from the <i class="semantic-i" id="dav_9781319322342_tEcXBctHN5">α</i> carbon of an amino acid. The enzyme threonine synthase promotes the PLP-dependent conversion of phosphohomoserine to threonine. Suggest a mechanism for this reaction.</p>
<figure class="figure lm_img_lightbox unnum c5 center" id="dav_9781319322342_R51WVVtnND">
<img alt="Phosphohomoserine is shown as a circle labeled P bonded to O bonded to C H 2 bonded to C H 2 bonded to C H bonded to N H 3 above with a positive charge on N and bonded to C O O minus to the right. An arrow points right accompanied by a curved arrow showing the addition of H 2 O and loss of P subscript i end subscript with P L P in the inflection point where they meet. This yields threonine, which is C H 3 bonded to C H bonded to O H below and to C H to the right bonded to N H 3 above with a positive charge on N and to C O O minus on the right." class="figure" id="dav_9781319322342_yc9GICAXkt" src="../images/nelsonlehnpob8e_22_un10_321631.png"/>
</figure></li>
<li id="dav_9781319322342_cwdbXLLdv2"><p class="question noindent" epub:type="question" id="dav_9781319322342_SgAjpztUT1"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_InFFwp62F9" id="dav_9781319322342_hl6AVR55Oy">4</a>. <strong class="important" id="dav_9781319322342_b5WUtUrpzK"><span aria-label="839" epub:type="pagebreak" id="page839" role="doc-pagebreak"/>Transformation of Aspartate to Asparagine</strong> There are two routes for transforming aspartate to asparagine at the expense of ATP. Many bacteria have an asparagine synthetase that uses ammonium ion as the nitrogen donor. Mammals have an asparagine synthetase that uses glutamine as the nitrogen donor. Given that the latter requires an extra ATP (for the synthesis of glutamine), why do mammals use this route?</p></li>
<li id="dav_9781319322342_KPskkRcpRJ"><p class="question noindent" epub:type="question" id="dav_9781319322342_IfDTMq0cQF"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_lV6Dq2Tv0L" id="dav_9781319322342_ffYwrnUgq4">5</a>. <strong class="important" id="dav_9781319322342_HEVJQ1tmPD">Equation for the Synthesis of Aspartate from Glucose</strong> Write the net equation for the synthesis of aspartate (a nonessential amino acid) from glucose, carbon dioxide, and ammonia.</p></li>
<li id="dav_9781319322342_fgNFpv1CHC"><p class="question noindent" epub:type="question" id="dav_9781319322342_uO8t45qwsx"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_dRzC5Ehq5N" id="dav_9781319322342_wwzmBEUtDk">6</a>. <img alt="" aria-hidden="true" class="decorative size-large inline" id="dav_9781319322342_xeXN0z1TGw" role="presentation" src="../images/nelsonlehnpob8e_01_un06_PG037.png"/><span class="keep" id="dav_9781319322342_VS8nat51fl"> </span><strong class="important" id="dav_9781319322342_axtRGih0El">Asparagine Synthetase Inhibitors in Leukemia Therapy</strong> Mammalian asparagine synthetase is a glutamine-dependent amidotransferase. Efforts to identify an effective inhibitor of human asparagine synthetase for use in chemotherapy for patients with leukemia have focused not on the amino-terminal glutaminase domain but on the carboxyl-terminal synthetase active site. Explain why the glutaminase domain is not a promising target for a useful drug.</p></li>
<li id="dav_9781319322342_a8zWFQrV35"><p class="question noindent" epub:type="question" id="dav_9781319322342_D7pwceXLMI"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_dD0i9oxZaX" id="dav_9781319322342_8sORJzkFGh">7</a>. <img alt="" aria-hidden="true" class="decorative size-large inline" id="dav_9781319322342_SAOUVnTLhU" role="presentation" src="../images/nelsonlehnpob8e_01_un06_PG037.png"/><span class="keep" id="dav_9781319322342_BKyKhDHwf2"> </span><strong class="important" id="dav_9781319322342_V5OwMiThNF">Phenylalanine Hydroxylase Deficiency and Diet</strong> Tyrosine is normally a nonessential amino acid, but individuals with a genetic defect in phenylalanine hydroxylase require tyrosine in their diet for normal growth. Explain.</p></li>
<li id="dav_9781319322342_5lPlNCS4bp"><p class="question noindent" epub:type="question" id="dav_9781319322342_VM4sGYtEaG"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_w80IQkpgjw" id="dav_9781319322342_sn0eWmmSId">8</a>. <strong class="important" id="dav_9781319322342_3byboQuNxf">Arginine Biosynthesis</strong> The first step of arginine biosynthesis from glutamate acetylates glutamate on the <i class="semantic-i" id="dav_9781319322342_kcVpGIBVpo">α</i>-amino group. A subsequent step late in the same pathway removes the added acetyl group. What chemical problem is solved by adding and then removing an acetyl group, with none of the acetyl atoms appearing in the arginine product of the pathway?</p></li>
<li id="dav_9781319322342_oPHGNhVbY0"><p class="question noindent" epub:type="question" id="dav_9781319322342_QAWxVjNsDq"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_0nCteifxZE" id="dav_9781319322342_3gHuVP1a7N">9</a>. <strong class="important" id="dav_9781319322342_l02ToO4rYG">Cofactors for One-Carbon Transfer Reactions</strong> Most one-carbon transfers are promoted by one of three cofactors: biotin, tetrahydrofolate, or <i class="semantic-i" id="dav_9781319322342_uTo6YkPX4W">S</i>-adenosylmethionine. <i class="semantic-i" id="dav_9781319322342_uJRzUHIMlx">S</i>-Adenosylmethionine generally serves as a methyl group donor; the transfer potential of the methyl group in <span class="math" id="dav_9781319322342_PkDKep7DJH" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mi>N</mi><mn>5</mn></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper N Superscript 5" src="../images/MATH/nel_9781319228002_ch22_06EQ_0001.png"/></annotation-xml></semantics></math></span>-methyltetrahydrofolate is insufficient for most biosynthetic reactions. However, one example of the use of <span class="math" id="dav_9781319322342_OW4wvJra6b" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mi>N</mi><mn>5</mn></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper N Superscript 5" src="../images/MATH/nel_9781319228002_ch22_06EQ_0002.png"/></annotation-xml></semantics></math></span>-methyltetrahydrofolate in methyl group transfer is in methionine formation by the methionine synthase reaction; methionine is the immediate precursor of <i class="semantic-i" id="dav_9781319322342_AEGKTcI2yh">S</i>-adenosylmethionine (see <a class="crossref" href="nel_9781319228002_ch18_04.xhtml#dav_9781319322342_MRk8kPo3be" id="dav_9781319322342_GSG0rKPds8">Fig. 18-18</a>).</p>
<figure class="figure lm_img_lightbox unnum c5 center" id="dav_9781319322342_NMOXH8fUEK">
<img alt="Homocysteine is H S bonded to C H 2 bonded to C H 2 bonded to C H bonded to N H 3 above with a positive charge on N and to C O O minus to the right. An arrow labeled methionine synthase is accompanied by an arrow showing the addition italicized N end italics superscript 5 end superscript blue highlighted methyl nonhighlighted H subscript 4 end subscript folate and loss of H subscript 4 end subscript folate. This yields methionine, shown as C H 3 in a blue box bonded to nonhighlighted S bonded to C H 2 bonded to C H 2 bonded to C H bonded to N H 3 above with a positive charge on N and to C O O minus to the right." class="figure" id="dav_9781319322342_Q7gJxLetrC" src="../images/nelsonlehnpob8e_22_un11_321632.png"/>
</figure>
<p class="indent" id="dav_9781319322342_hEE2AwPDFk">Explain how the methyl group of <i class="semantic-i" id="dav_9781319322342_tNixXnpjCk">S</i>-adenosylmethionine can be derived from <span class="math" id="dav_9781319322342_xnYo08cw2f" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mi>N</mi><mn>5</mn></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper N Superscript 5" src="../images/MATH/nel_9781319228002_ch22_06EQ_0003.png"/></annotation-xml></semantics></math></span>-methyltetrahydrofolate, even though the transfer potential of the methyl group in <span class="math" id="dav_9781319322342_6WmprIImWL" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mi>N</mi><mn>5</mn></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper N Superscript 5" src="../images/MATH/nel_9781319228002_ch22_06EQ_0004.png"/></annotation-xml></semantics></math></span>-methyltetrahydrofolate is one-thousandth of that of <i class="semantic-i" id="dav_9781319322342_TbPTQCpilJ">S</i>-adenosylmethionine.</p></li>
<li id="dav_9781319322342_WvqHFtfQB2"><p class="question noindent" epub:type="question" id="dav_9781319322342_USa0O71sFP"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_1l06s3PzuS" id="dav_9781319322342_fCWr1V8E7Y">10</a>. <strong class="important" id="dav_9781319322342_itKTSa6eky">Concerted Regulation in Amino Acid Biosynthesis</strong> Various products of glutamine metabolism independently modulate the glutamine synthetase of <i class="semantic-i" id="dav_9781319322342_2rltrAAoEj">E. coli</i> (see <a class="crossref" href="nel_9781319228002_ch22_02.xhtml#dav_9781319322342_Pk5cW2G7uf" id="dav_9781319322342_awd64U8zgj">Fig. 22-8</a>). In this concerted inhibition, the extent of enzyme inhibition is greater than the sum of the separate inhibitions caused by each product. For <i class="semantic-i" id="dav_9781319322342_Ubjcj0IRHd">E. coli</i> grown in a medium rich in histidine, what is the advantage of concerted inhibition?</p></li>
<li id="dav_9781319322342_AnIGmnQ3z0"><p class="question noindent" epub:type="question" id="dav_9781319322342_VkAnolQeoy"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_emxs9Cavpg" id="dav_9781319322342_C6yAerIJK0">11</a>. <img alt="" aria-hidden="true" class="decorative size-large inline" id="dav_9781319322342_sjh0ino6kg" role="presentation" src="../images/nelsonlehnpob8e_01_un06_PG037.png"/><span class="keep" id="dav_9781319322342_EEAPY9bvny"> </span><strong class="important" id="dav_9781319322342_K42Jb4pI1v">Relationship between Folic Acid Deficiency and Anemia</strong> Folic acid deficiency, believed to be the most common vitamin deficiency, causes a type of anemia in which hemoglobin synthesis is impaired and erythrocytes do not mature properly. What is the metabolic relationship between hemoglobin synthesis and folic acid deficiency?</p></li>
<li id="dav_9781319322342_eGT88bD9EB"><p class="question noindent" epub:type="question" id="dav_9781319322342_xjtHux6ibF"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_XXNvoMOsp8" id="dav_9781319322342_QMWMQYQ7pO">12</a>. <strong class="important" id="dav_9781319322342_xgEoCxl1hm">Synthesis of Polyamines</strong> The metabolic amino acid ornithine is a direct precursor of the polyamine putrescine, shown here.</p>
<div class="informalequation" id="dav_9781319322342_6BrlA0aUPd" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="block"><semantics><mrow><msub><mrow><mtext>H</mtext></mrow><mn>3</mn></msub><mover><mrow><mtext>N</mtext></mrow><mn>+</mn></mover><mn>—</mn><msub><mrow><mtext>CH</mtext></mrow><mn>2</mn></msub><mn>—</mn><msub><mrow><mtext>CH</mtext></mrow><mn>2</mn></msub><mn>—</mn><msub><mrow><mtext>CH</mtext></mrow><mn>2</mn></msub><mn>—</mn><msub><mrow><mtext>CH</mtext></mrow><mn>2</mn></msub><mn>—</mn><mover><mrow><mtext>N</mtext></mrow><mn>+</mn></mover><msub><mrow><mtext>H</mtext></mrow><mn>3</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper H Subscript 3 Baseline ModifyingAbove upper N With plus em-dash CH Subscript 2 Baseline em-dash CH Subscript 2 Baseline em-dash CH Subscript 2 Baseline em-dash CH Subscript 2 Baseline em-dash ModifyingAbove upper N With plus upper H Subscript 3 Baseline" src="../images/MATH/nel_9781319228002_ch22_06EQ_0005.png"/></annotation-xml></semantics></math></div>
<p class="indent" id="dav_9781319322342_xG6We1kHRK">Subsequent reactions convert putrescine to spermine and spermidine. What type of reaction is required to convert ornithine to putrescine, and what enzymatic cofactor is needed?</p></li>
<li id="dav_9781319322342_V5jpDRfEFw"><p class="question noindent" epub:type="question" id="dav_9781319322342_MFBp8OVaLq"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_OmPagQdmEd" id="dav_9781319322342_nvSMQrJhKa">13</a>. <strong class="important" id="dav_9781319322342_NeJ61ASBhj">Nucleotide Biosynthesis in Amino Acid Auxotrophic Bacteria</strong> Wild-type <i class="semantic-i" id="dav_9781319322342_l5PS0sFhoZ">E. coli</i> cells can synthesize all 20 common amino acids, but some mutants, called amino acid auxotrophs, are unable to synthesize a specific amino acid and require its addition to the culture medium for optimal growth. Besides their role in protein synthesis, some amino acids are also precursors for other nitrogenous cell products. Consider the three amino acid auxotrophs that are unable to synthesize glycine, glutamine, and aspartate, respectively. For each mutant, what nitrogenous products other than proteins would the cell fail to synthesize?</p></li>
<li id="dav_9781319322342_GJv0W0N79M"><p class="question noindent" epub:type="question" id="dav_9781319322342_Hxu5j7v4Y7"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_2o2Hc3PepA" id="dav_9781319322342_wTs1FSgzlX">14</a>. <strong class="important" id="dav_9781319322342_m2tk3EiiJA">Inhibitors of Nucleotide Biosynthesis</strong> Suggest a mechanism for the inhibition of alanine racemase by <span class="smallcap" id="dav_9781319322342_nk25cnaj9t">l</span>-fluoroalanine.</p></li>
<li id="dav_9781319322342_xaTQ3mQ3VE"><p class="question noindent" epub:type="question" id="dav_9781319322342_jNlL0eDKCe"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_USaV86wjWY" id="dav_9781319322342_pMVXkLrWpR">15</a>. <img alt="" aria-hidden="true" class="decorative size-large inline" id="dav_9781319322342_hx0s0LJdQh" role="presentation" src="../images/nelsonlehnpob8e_01_un06_PG037.png"/><span class="keep" id="dav_9781319322342_nOXFQazRFx"> </span><strong class="important" id="dav_9781319322342_k0huEkPv5R">Mode of Action of Sulfa Drugs</strong> Some bacteria require <i class="semantic-i" id="dav_9781319322342_vtdDWmntkO">p</i>-aminobenzoate in the culture medium for normal growth, and their growth is severely inhibited by the addition of sulfanilamide, one of the earliest sulfa drugs. Moreover, in the presence of this drug, 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR; see <a class="crossref" href="nel_9781319228002_ch22_05.xhtml#dav_9781319322342_UC3Mf8KMCg" id="dav_9781319322342_50tUrapPGK">Fig. 22-35</a>) accumulates in the culture medium. Addition of excess <i class="semantic-i" id="dav_9781319322342_MaRs7RP5of">p</i>-aminobenzoate reverses these effects.</p>
<figure class="figure lm_img_lightbox unnum c4 center" id="dav_9781319322342_wNHzltbTj3">
<img alt="Italicized p end italics-aminobenzoate is a benzene ring with its left side vertex bonded to N H 2 and its right side vertex bonded to C double bonded to O to the upper right and bonded to O minus to the lower right. Sulfanilamide is a benzene ring with its left side vertex bonded to N H 2 and its right side vertex bonded to S double bonded to O above and below and bonded to N H 2 to the right." class="figure" id="dav_9781319322342_mF6r1T7WD4" src="../images/nelsonlehnpob8e_22_un13_321634.png"/>
</figure>
<ol class="ol-alpha-lc" id="dav_9781319322342_vzpVFUcl6E">
<li id="dav_9781319322342_6RFERRTu9x">What is the role of <i class="semantic-i" id="dav_9781319322342_y56cXGDZ0N">p</i>-aminobenzoate in these bacteria? (Hint: See <a class="crossref" href="nel_9781319228002_ch18_04.xhtml#dav_9781319322342_H5ohjr49zv" id="dav_9781319322342_kt2UkwXlt0">Fig. 18-16</a>.)</li>
<li id="dav_9781319322342_Rpnex4A1aJ">Why does AICAR accumulate in the presence of sulfanilamide?</li>
<li id="dav_9781319322342_AdnF5Z3Nxy">Why does addition of excess <i class="semantic-i" id="dav_9781319322342_RMUSUdpkUU">p</i>-aminobenzoate reverse the inhibition and accumulation?</li>
</ol></li>
<li id="dav_9781319322342_u7AIgJirfs"><p class="question noindent" epub:type="question" id="dav_9781319322342_FcpRNHGWpU"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_yWBHRIOM4X" id="dav_9781319322342_3KouJE55UT">16</a>. <strong class="important" id="dav_9781319322342_fPGPP3ceZW">Purine Biosynthesis</strong> Which atoms of the purine ring derive from the amide nitrogen of glutamine?</p>
<ol class="ol-alpha-lc" id="dav_9781319322342_hb7FteXDEN">
<li id="dav_9781319322342_63vAqjjFyb">N-1</li>
<li id="dav_9781319322342_dM7VNp59Bk">N-3</li>
<li id="dav_9781319322342_41x3crcjB5">N-7</li>
<li id="dav_9781319322342_h20GnLUGY6">N-9</li>
</ol></li>
<li id="dav_9781319322342_k6gni4EMrD"><p class="question noindent" epub:type="question" id="dav_9781319322342_InBUiE52Xz"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_ndSSaFVYc0" id="dav_9781319322342_GzE2uKm08B">17</a>. <strong class="important" id="dav_9781319322342_5ZK4zxkKkH">Pathway of Carbon in Pyrimidine Biosynthesis</strong> Predict the locations of <span class="math" id="dav_9781319322342_n0rxWt0FYi" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow/><mrow><mn>14</mn></mrow></msup><mtext>​</mtext><mtext>C</mtext></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Superscript 14 Baseline zero width space upper C" src="../images/MATH/nel_9781319228002_ch22_06EQ_0006.png"/></annotation-xml></semantics></math></span> in orotate isolated from cells grown on a small amount of uniformly labeled <span class="math" id="dav_9781319322342_griZZk2Os8" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mo stretchy="false">[</mo><mrow><mn>14</mn></mrow></msup><mtext>​</mtext><mtext>C]</mtext></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Superscript 14 Baseline zero width space upper C right-bracket" src="../images/MATH/nel_9781319228002_ch22_06EQ_0007.png"/></annotation-xml></semantics></math></span>succinate. Justify your prediction.</p></li>
<li id="dav_9781319322342_idep8jd7Ul"><p class="question noindent" epub:type="question" id="dav_9781319322342_TViQMgIGGB"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_SXwREBVkHc" id="dav_9781319322342_jgCqVehlEP">18</a>. <strong class="important" id="dav_9781319322342_56RLZJmCYd"><span aria-label="840" epub:type="pagebreak" id="page840" role="doc-pagebreak"/>Nucleotides as Poor Sources of Energy</strong> Under starvation conditions, organisms can use proteins and amino acids as sources of energy. Deamination of amino acids produces carbon skeletons that can enter the glycolytic pathway and the citric acid cycle to produce energy in the form of ATP. Nucleotides are not similarly degraded for use as energy-yielding fuels. What observations about cellular physiology support this statement? What aspect of the structure of nucleotides makes them a relatively poor source of energy?</p></li>
<li id="dav_9781319322342_QtkdYUI2Mj"><p class="question noindent" epub:type="question" id="dav_9781319322342_cVIrpBbn3u"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_nxIO4nAYfj" id="dav_9781319322342_Br2FQnE7qD">19</a>. <img alt="" aria-hidden="true" class="decorative size-large inline" id="dav_9781319322342_uFi2lpvZ1B" role="presentation" src="../images/nelsonlehnpob8e_01_un06_PG037.png"/><span class="keep" id="dav_9781319322342_5P8VdJYZWX"> </span><strong class="important" id="dav_9781319322342_7y84bY1fXb">Treatment of Gout</strong> Physicians use allopurinol (see <a class="crossref" href="nel_9781319228002_ch22_05.xhtml#dav_9781319322342_5DsLaS9nUL" id="dav_9781319322342_QbbJp6dfGz">Fig. 22-50</a>), an inhibitor of xanthine oxidase, to treat chronic gout. Explain the biochemical basis for this treatment. Patients treated with allopurinol sometimes develop xanthine stones in the kidneys, although the incidence of kidney damage is much lower than in untreated gout. Explain this observation in light of these solubilities in urine: uric acid, 0.15 g/L; xanthine, 0.05 g/L; and hypoxanthine, 1.4 g/L.</p></li>
<li id="dav_9781319322342_FMW2YmTG2G"><p class="question noindent" epub:type="question" id="dav_9781319322342_YeK35v6NqW"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_oJXVO7mvcv" id="dav_9781319322342_YQCqktdY6G">20</a>. <img alt="" aria-hidden="true" class="decorative size-large inline" id="dav_9781319322342_5jTXRVbGFp" role="presentation" src="../images/nelsonlehnpob8e_01_un06_PG037.png"/><span class="keep" id="dav_9781319322342_EUMQMc0Iet"> </span><strong class="important" id="dav_9781319322342_z0ojapK6h5">Antibiotics That Inhibit Dihydrofolate Reductase</strong> Trimethoprim, a commonly used antibiotic, inhibits the bacterial form of dihydrofolate reductase much more than it inhibits the mammalian enzyme. What metabolic processes described in this chapter are affected by depleting tetrahydrofolate?</p></li>
</ul>
<section class="subsect1" id="dav_9781319322342_IuaWafUnLJ">
<header id="dav_9781319322342_T0HBREEldI"><h5 class="level1 v4" id="dav_9781319322342_35kcGFuam2">DATA ANALYSIS PROBLEM</h5></header>
<ul class="ul-no-mark" id="dav_9781319322342_LFYagKjqf7">
<li id="dav_9781319322342_Rdw598Sm16"><p class="question noindent" epub:type="question" id="dav_9781319322342_lYs9BdKyP4"><a class="crossref" href="nel_9781319228002_EM_answers.xhtml#dav_9781319322342_CxTN3BApIK" id="dav_9781319322342_kkAjyNC7VH">21</a>. <strong class="important" id="dav_9781319322342_UNFFrp8PC8">Use of Modern Molecular Techniques to Determine the Synthetic Pathway of a Novel Amino Acid</strong> Most of the biosynthetic pathways described in this chapter were determined before the development of recombinant DNA technology and genomics, so the techniques were quite different from those that researchers would use today. Here we explore an example of the use of modern molecular techniques to investigate the pathway of synthesis of a novel amino acid, (2<i class="semantic-i" id="dav_9781319322342_nHIPhmNp8D">S</i>)-4-amino-2-hydroxybutyrate (AHBA). The techniques mentioned here are described in various places in the text; this problem is designed to show how they can be integrated in a comprehensive study.</p>
<p class="indent" id="dav_9781319322342_zlbLn6cN6W">AHBA is a <i class="semantic-i" id="dav_9781319322342_6k1UM7TmhM">γ</i>-amino acid that is a component of some aminoglycoside antibiotics, including the antibiotic butirosin. Antibiotics modified by the addition of an AHBA residue are often more resistant to inactivation by bacterial antibiotic-resistance enzymes. As a result, understanding how AHBA is synthesized and added to antibiotics is useful in the design of pharmaceuticals.</p>
<p class="indent" id="dav_9781319322342_EvvhhcclCL">In an article published in 2005, Li and coworkers describe how they determined the synthetic pathway of AHBA from glutamate.</p>
<figure class="figure lm_img_lightbox unnum c4 center" id="dav_9781319322342_AMySI8cuSU">
<img alt="Two zigzag chains are numbered from left to right for consistency. Glutamate: a five-carbon zigzag chain has C 1 bonded to O minus to the upper left and double bonded to O below, C 2 hashed wedge bonded to N H 3 above with a positive charge on N, and C 5 double bonded to O to the upper right and bonded to O minus below. A H B A: A four-carbon zigzag chain has C 1 bonded to N H 3 to the left with a positive charge on N, C 3 hashed wedge bonded to O H, and C 4 double bonded to O to the upper right and bonded to O minus below." class="figure" id="dav_9781319322342_NVigBCgoDJ" src="../images/nelsonlehnpob8e_22_un14_321635.png"/>
</figure>
<ol class="ol-alpha-lc" id="dav_9781319322342_30HWyDpu3K">
<li id="dav_9781319322342_urLVVTmJLd">Briefly describe the chemical transformations needed to convert glutamate to AHBA. At this point, don’t be concerned about the <i class="semantic-i" id="dav_9781319322342_vY4XyjNPfe">order</i> of the reactions.
<p class="indent" id="dav_9781319322342_wohshaFbTE">Li and colleagues began by cloning the butirosin biosynthetic gene cluster from the bacterium <i class="semantic-i" id="dav_9781319322342_ji0I0WJWVh">Bacillus circulans</i>, which makes large quantities of butirosin. They identified five genes that are essential for the pathway: <i class="semantic-i" id="dav_9781319322342_Q7c0OEvkYP">btrI, <i class="semantic-i" id="dav_9781319322342_paOpOGJTel">btrJ</i>,<i class="semantic-i" id="dav_9781319322342_OKpHuMyWxc"> btrK</i>, btrO</i><i class="semantic-i" id="dav_9781319322342_aruxYYLRdc"/>, and <i class="semantic-i" id="dav_9781319322342_eVNEOI4btT">btrV</i>. They cloned these genes into <i class="semantic-i" id="dav_9781319322342_Mpi93Fh55B">E. coli</i> plasmids that allow overexpression of the genes, producing proteins with “histidine tags” fused to their amino termini to facilitate purification (see <a class="crossref" href="nel_9781319228002_ch09_02.xhtml#page313" id="dav_9781319322342_G9nlfygQ0p">p. 313</a>).</p>
<p class="indent" id="dav_9781319322342_usfBHtwlsl">The predicted amino acid sequence of the BtrI protein showed strong homology to known acyl carrier proteins (see <a class="crossref" href="nel_9781319228002_ch21_02.xhtml#dav_9781319322342_a77MUnjd18" id="dav_9781319322342_iW2dZkJU4T">Fig. 21-5</a>). Using mass spectrometry, Li and colleagues found a molecular mass of 11,812 for the purified BtrI protein (including the His tag). When the purified BtrI was incubated with coenzyme A and an enzyme known to attach CoA to other acyl carrier proteins, the majority molecular species had an <span class="math" id="dav_9781319322342_hglb5E72YQ" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>M</mi><mtext>r</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper M Subscript r" src="../images/MATH/nel_9781319228002_ch22_06EQ_0008.png"/></annotation-xml></semantics></math></span> of 12,153.</p></li>
<li id="dav_9781319322342_2NKEZUKg2a">How would you use these data to argue that BtrI can function as an acyl carrier protein with a CoA prosthetic group?
<p class="indent" id="dav_9781319322342_IwcjTkHKVv">Using standard terminology, Li and coauthors called the form of the protein lacking CoA apo-BtrI and the form with CoA (linked as in <a class="crossref" href="nel_9781319228002_ch21_02.xhtml#dav_9781319322342_a77MUnjd18" id="dav_9781319322342_pVlHHNGD5C">Fig. 21-5</a>) holo-BtrI. When holo-BtrI was incubated with glutamine, ATP, and purified BtrJ protein, the holo-BtrI species of <span class="math" id="dav_9781319322342_V4WcT4LXNF" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>M</mi><mtext>r</mtext></msub><mtext> </mtext><mn>12,153</mn></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper M Subscript r Baseline 12,153" src="../images/MATH/nel_9781319228002_ch22_06EQ_0009.png"/></annotation-xml></semantics></math></span> was replaced with a species of <span class="math" id="dav_9781319322342_92ruKkEBSl" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>M</mi><mtext>r</mtext></msub><mtext> </mtext><mn>12,281</mn></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper M Subscript r Baseline 12,281" src="../images/MATH/nel_9781319228002_ch22_06EQ_0010.png"/></annotation-xml></semantics></math></span>, corresponding to the thioester of glutamate and holo-BtrI. Based on these data, the authors proposed the following structure for the <span class="math" id="dav_9781319322342_xXG31G1DwL" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>M</mi><mtext>r</mtext></msub><mtext> </mtext><mn>12,281</mn></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper M Subscript r Baseline 12,281" src="../images/MATH/nel_9781319228002_ch22_06EQ_0011.png"/></annotation-xml></semantics></math></span> species, <i class="semantic-i" id="dav_9781319322342_OHK0Od9A0o">γ</i>-glutamyl-<i class="semantic-i" id="dav_9781319322342_8jwQVW4rxX">S</i>-BtrI:</p>
<figure class="figure lm_img_lightbox unnum c2 center" id="dav_9781319322342_JEkjFxYtLN">
<img alt="Numbered from left to right, a five-carbon zigzag chain has C 1 bonded to O minus to the upper left and double bonded to O below, C 2 hashed wedge bonded to N H 3 above with a positive charge on N, and C 5 double bonded to O to the upper right and bonded to S below connected by a wavy vertical line to B t r l." class="figure" id="dav_9781319322342_CI0Cq2R1f6" src="../images/nelsonlehnpob8e_22_un15_321636.png"/>
</figure>
</li>
<li id="dav_9781319322342_LEb3NN1pHF">What other structure(s) is (are) consistent with the data above?</li>
<li id="dav_9781319322342_caF9CKW1UQ">Li and coauthors argued that the structure shown here (<i class="semantic-i" id="dav_9781319322342_PfoMlZTtZt">γ</i>-glutamyl-<i class="semantic-i" id="dav_9781319322342_ECM0LF2R6r">S</i>-BtrI) is likely to be correct because the <i class="semantic-i" id="dav_9781319322342_69lGb2CqAg">α</i>-carboxyl group must be removed at some point in the synthetic process. Explain the chemical basis of this argument. (Hint: See <a class="crossref" href="nel_9781319228002_ch18_02.xhtml#dav_9781319322342_npEf3Z8eMM" id="dav_9781319322342_GqGYR5PYhn">Fig. 18-6</a>, reaction C.)
<p class="indent" id="dav_9781319322342_u7ZOA9XfYw">The BtrK protein showed significant homology to PLP-dependent amino acid decarboxylases, and BtrK isolated from <i class="semantic-i" id="dav_9781319322342_hEu3kfuibT">E. coli</i> was found to contain tightly bound PLP. When <i class="semantic-i" id="dav_9781319322342_X2tjnNvnJf">γ</i>-glutamyl-<i class="semantic-i" id="dav_9781319322342_pD9iwyJ7FB">S</i>-BtrI was incubated with purified BtrK, a molecular species of <span class="math" id="dav_9781319322342_EX2DzBwdeb" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>M</mi><mtext>r</mtext></msub><mtext> </mtext><mn>12,240</mn></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper M Subscript r Baseline 12,240" src="../images/MATH/nel_9781319228002_ch22_06EQ_0012.png"/></annotation-xml></semantics></math></span> was produced.</p></li>
<li id="dav_9781319322342_b6nY02eg1n">What is the most likely structure of this species?</li>
<li id="dav_9781319322342_da6iHe4L6m">When the investigators incubated glutamate and ATP with purified BtrI, BtrJ, and BtrK, they found a molecular species of <span class="math" id="dav_9781319322342_6WdaOzzqkl" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>M</mi><mtext>r</mtext></msub><mtext> </mtext><mn>12,370</mn></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper M Subscript r Baseline 12,370" src="../images/MATH/nel_9781319228002_ch22_06EQ_0013.png"/></annotation-xml></semantics></math></span>. What is the most likely structure of this species? Hint: Remember that BtrJ can use ATP to <i class="semantic-i" id="dav_9781319322342_RSJ7ESQLS4">γ</i>-glutamylate nucleophilic groups.
<p class="indent" id="dav_9781319322342_U3GRX4rjwU">Li and colleagues found that BtrO is homologous to monooxygenase enzymes (see <a class="crossref" href="nel_9781319228002_ch21_02.xhtml#dav_9781319322342_pzLbcZ1MdJ" id="dav_9781319322342_6kGrFOtNK0">Box 21-1</a>) that hydroxylate alkanes, using FMN as a cofactor, and BtrV is homologous to an NAD(P)H oxidoreductase. Two other genes in the cluster, <i class="semantic-i" id="dav_9781319322342_2nwf6V0ydo">btrG</i> and <i class="semantic-i" id="dav_9781319322342_XTtB1CQVMj">btrH</i>, probably encode enzymes that remove the <i class="semantic-i" id="dav_9781319322342_IQuZP7MR2p">γ</i>-glutamyl group and attach AHBA to the target antibiotic molecule.</p></li>
<li id="dav_9781319322342_ZDBrC670lC">Based on these data, propose a plausible pathway for the synthesis of AHBA and its addition to the target antibiotic. Include the enzymes that catalyze each step and any other substrates or cofactors needed (ATP, NAD, etc.).</li>
</ol></li>
</ul>
</section>
</section>
<section class="subsect1" id="dav_9781319322342_DsFHxNqE0C">
<header id="dav_9781319322342_x7A0SMt7Zy"><h4 class="level1 v1" id="dav_9781319322342_JJ6oZURCzu">References</h4></header>
<ul class="ul-no-mark" id="dav_9781319322342_5p9KfQKm1C">
<li class="biblioentry" id="dav_9781319322342_gHrZrrDb9q"><strong class="important" id="dav_9781319322342_dzBmsuWRid">Li, Y., N.M. Llewellyn, R. Giri, F. Huang, and J.B. Spencer. 2005.</strong> Biosynthesis of the unique amino acid side chain of butirosin: possible protective-group chemistry in an acyl carrier protein–mediated pathway. <i class="semantic-i" id="dav_9781319322342_vnF56IypkB">Chem. Biol.</i> 12:665–675.</li>
</ul>
</section>
</section>
</body>
</html>